FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090380198> ?p ?o ?g. }

• W2090380198 endingPage "1087" @default.
• W2090380198 startingPage "1078" @default.
• W2090380198 abstract "Objective. Zinc supplementation has been shown to contribute to inhibition of liver fibrosis and improvement in hepatic encephalopathy. However, little is known about the anti-inflammatory effect of zinc on hepatitis C virus (HCV)-related chronic liver disease (CLD). We therefore examined the effects of zinc administration on inflammatory activity and fibrosis in the liver of patients with HCV-related CLD. Material and methods. Polaprezinc, a complex of zinc and l-carnosine, was administrated at 225 mg/day for 6 months to 14 patients with HCV-related CLD, in addition to their ongoing prescriptions. Peripheral blood cell counts, liver-related biochemical parameters, serological markers for liver fibrosis, HCV-RNA loads, and serum levels of zinc and ferritin were evaluated before and after zinc administration. Results. Serum zinc concentrations were positively correlated with hepatic reserve before zinc supplementation. A significant increase in serum zinc level was observed after zinc supplementation (64±15 versus 78±26 mg/dl, p=0.0156). Treatment with polaprezinc significantly decreased serum aminotransferase levels (aspartate aminotransferase (AST): 92±33 versus 63±23 IU/l, p=0.0004; alanine aminotransferase (ALT): 106±43 versus 65±32 IU/l, p=0.0002), whereas alkaline phosphatase levels were significantly increased (305±117 versus 337±118 U/l, p=0.0020). Serum ferritin levels were significantly decreased by treatment with polaprezinc (158±141 versus 101±80 ng/ml, p=0.0117). The reduction rate of ALT levels by polaprezinc was positively correlated with that of ferritin (r2=0.536, p=0.0389). There was a tendency toward a decrease in serum type IV collagen 7S levels after treatment with polaprezinc. However, administration of polaprezinc did not affect peripheral blood cell counts, other liver function tests, or HCV-RNA loads. Conclusions. These findings suggest that polaprezinc exerts an anti-inflammatory effect on the liver in patients with HCV-related CLD by reducing iron overload." @default.
• W2090380198 created "2016-06-24" @default.
• W2090380198 creator A5001020117 @default.
• W2090380198 creator A5008855260 @default.
• W2090380198 creator A5017931660 @default.
• W2090380198 creator A5022493430 @default.
• W2090380198 creator A5032563585 @default.
• W2090380198 creator A5035974021 @default.
• W2090380198 creator A5055436829 @default.
• W2090380198 creator A5057839325 @default.
• W2090380198 creator A5068329317 @default.
• W2090380198 creator A5077098457 @default.
• W2090380198 creator A5077122267 @default.
• W2090380198 creator A5077809138 @default.
• W2090380198 date "2007-01-01" @default.
• W2090380198 modified "2023-10-16" @default.
• W2090380198 title "Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease" @default.
• W2090380198 cites W1564651967 @default.
• W2090380198 cites W1585218731 @default.
• W2090380198 cites W160412982 @default.
• W2090380198 cites W1675199507 @default.
• W2090380198 cites W1973117081 @default.
• W2090380198 cites W1979139937 @default.
• W2090380198 cites W1981900811 @default.
• W2090380198 cites W1982153642 @default.
• W2090380198 cites W1989276920 @default.
• W2090380198 cites W1996598277 @default.
• W2090380198 cites W2008030481 @default.
• W2090380198 cites W2010693718 @default.
• W2090380198 cites W2013537521 @default.
• W2090380198 cites W2014271571 @default.
• W2090380198 cites W2018393523 @default.
• W2090380198 cites W2019081326 @default.
• W2090380198 cites W2019943793 @default.
• W2090380198 cites W2026543492 @default.
• W2090380198 cites W2027405903 @default.
• W2090380198 cites W2035948441 @default.
• W2090380198 cites W2039612317 @default.
• W2090380198 cites W2041745785 @default.
• W2090380198 cites W2057199729 @default.
• W2090380198 cites W2066615574 @default.
• W2090380198 cites W2072883694 @default.
• W2090380198 cites W2074122095 @default.
• W2090380198 cites W2091124986 @default.
• W2090380198 cites W2094400862 @default.
• W2090380198 cites W2101964422 @default.
• W2090380198 cites W2104619231 @default.
• W2090380198 cites W2126100775 @default.
• W2090380198 cites W2136886946 @default.
• W2090380198 cites W2136966666 @default.
• W2090380198 cites W2143279312 @default.
• W2090380198 cites W2146787258 @default.
• W2090380198 cites W2149957454 @default.
• W2090380198 cites W2152660499 @default.
• W2090380198 cites W2152805462 @default.
• W2090380198 cites W2167097948 @default.
• W2090380198 cites W2408410950 @default.
• W2090380198 cites W4254304797 @default.
• W2090380198 cites W54039431 @default.
• W2090380198 doi "https://doi.org/10.1080/00365520701272409" @default.
• W2090380198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17710674" @default.
• W2090380198 hasPublicationYear "2007" @default.
• W2090380198 type Work @default.
• W2090380198 sameAs 2090380198 @default.
• W2090380198 citedByCount "47" @default.
• W2090380198 countsByYear W20903801982012 @default.
• W2090380198 countsByYear W20903801982013 @default.
• W2090380198 countsByYear W20903801982014 @default.
• W2090380198 countsByYear W20903801982015 @default.
• W2090380198 countsByYear W20903801982017 @default.
• W2090380198 countsByYear W20903801982018 @default.
• W2090380198 countsByYear W20903801982019 @default.
• W2090380198 countsByYear W20903801982020 @default.
• W2090380198 countsByYear W20903801982021 @default.
• W2090380198 countsByYear W20903801982022 @default.
• W2090380198 countsByYear W20903801982023 @default.
• W2090380198 crossrefType "journal-article" @default.
• W2090380198 hasAuthorship W2090380198A5001020117 @default.
• W2090380198 hasAuthorship W2090380198A5008855260 @default.
• W2090380198 hasAuthorship W2090380198A5017931660 @default.
• W2090380198 hasAuthorship W2090380198A5022493430 @default.
• W2090380198 hasAuthorship W2090380198A5032563585 @default.
• W2090380198 hasAuthorship W2090380198A5035974021 @default.
• W2090380198 hasAuthorship W2090380198A5055436829 @default.
• W2090380198 hasAuthorship W2090380198A5057839325 @default.
• W2090380198 hasAuthorship W2090380198A5068329317 @default.
• W2090380198 hasAuthorship W2090380198A5077098457 @default.
• W2090380198 hasAuthorship W2090380198A5077122267 @default.
• W2090380198 hasAuthorship W2090380198A5077809138 @default.
• W2090380198 hasConcept C126322002 @default.
• W2090380198 hasConcept C134018914 @default.
• W2090380198 hasConcept C160160445 @default.
• W2090380198 hasConcept C178790620 @default.
• W2090380198 hasConcept C181199279 @default.
• W2090380198 hasConcept C185592680 @default.
• W2090380198 hasConcept C203014093 @default.
• W2090380198 hasConcept C2522874641 @default.
• W2090380198 hasConcept C2776408679 @default.

• next